Evaluation of the Semmes–Weinstein filaments and a questionnaire to assess chemotherapy-induced peripheral neuropathy

Objective This study aims to assess the use of Semmes–Weinstein monofilaments (SWMs) and of the Chemotherapy-Induced Neurotoxicity Questionnaire (CINQ) in the detection of chemotherapy-induced peripheral neuropathy (CIPN). Method It is a comparative and cross-sectional study performed in a philanthr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Supportive care in cancer 2014-10, Vol.22 (10), p.2767-2773
Hauptverfasser: da Silva Simão, Delma Aurélia, Teixeira, Antônio Lúcio, Souza, Raissa Silva, de Paula Lima, Elenice Dias Ribeiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2773
container_issue 10
container_start_page 2767
container_title Supportive care in cancer
container_volume 22
creator da Silva Simão, Delma Aurélia
Teixeira, Antônio Lúcio
Souza, Raissa Silva
de Paula Lima, Elenice Dias Ribeiro
description Objective This study aims to assess the use of Semmes–Weinstein monofilaments (SWMs) and of the Chemotherapy-Induced Neurotoxicity Questionnaire (CINQ) in the detection of chemotherapy-induced peripheral neuropathy (CIPN). Method It is a comparative and cross-sectional study performed in a philanthropic general hospital, located in the state of Minas Gerais, Brazil. One hundred seventeen individuals have participated in this study; they were divided into two groups: patients ( n  = 87) treated with oxaliplatin, paclitaxel, or docetaxel and controls ( n  = 30) without malignant disease. Results There were statistically significant differences between groups for all symptoms assessed by means of the CINQ. Lower limbs were more severely affected. Patients had increased frequency and severity of changes in all points assessed with SWM compared with controls. In the analyses of concordance between CINQ and SWM, kappa = 0.320 ( p  
doi_str_mv 10.1007/s00520-014-2275-3
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_1559516963</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A384207812</galeid><sourcerecordid>A384207812</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-473c80c08fae41b505b8fefe507a64f7b9d47aef60939e4aa7ee59525c6a30de3</originalsourceid><addsrcrecordid>eNp1kcuKFDEYhYMoTjv6AG4k4LrGXDtVy2EYLzDgQsVl-Dv1ZzpDVVImVQ698x18Q5_ElD3eQAkkkHzn5CSHkKecnXHGzIvCmBasYVw1QhjdyHtkw5WUjZGyu082rFO8UVLrE_KolBvGuDFaPCQnQrWcC95uyO3lZxgWmEOKNHk675G-w3HE8u3L148YYpnrRH0YYMQ4Fwqxp0A_LVhWSYSQkc6JQilYCnV7HFP1yDAdmhD7xWFPJ8xhWvcGGnHJaYJ5f3hMHngYCj65W0_Jh5eX7y9eN1dvX725OL9qnJLd3CgjXcscaz2g4jvN9K716FEzA1vlza7rlQH0W9bJDhWAQdSdFtptQbIe5Sl5fvSdcvqR2t6kJcd6peW6knzbbeVv6hoGtCH6NGdwYyjOnstWCWZaLip19g-qjh7H4FLE-k34t4AfBS6nUjJ6O-UwQj5YzuzaoD02aGuDdm3QrlGe3QVediP2vxQ_K6uAOAKlHsVrzH-86L-u3wF6yahR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1559516963</pqid></control><display><type>article</type><title>Evaluation of the Semmes–Weinstein filaments and a questionnaire to assess chemotherapy-induced peripheral neuropathy</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>da Silva Simão, Delma Aurélia ; Teixeira, Antônio Lúcio ; Souza, Raissa Silva ; de Paula Lima, Elenice Dias Ribeiro</creator><creatorcontrib>da Silva Simão, Delma Aurélia ; Teixeira, Antônio Lúcio ; Souza, Raissa Silva ; de Paula Lima, Elenice Dias Ribeiro</creatorcontrib><description>Objective This study aims to assess the use of Semmes–Weinstein monofilaments (SWMs) and of the Chemotherapy-Induced Neurotoxicity Questionnaire (CINQ) in the detection of chemotherapy-induced peripheral neuropathy (CIPN). Method It is a comparative and cross-sectional study performed in a philanthropic general hospital, located in the state of Minas Gerais, Brazil. One hundred seventeen individuals have participated in this study; they were divided into two groups: patients ( n  = 87) treated with oxaliplatin, paclitaxel, or docetaxel and controls ( n  = 30) without malignant disease. Results There were statistically significant differences between groups for all symptoms assessed by means of the CINQ. Lower limbs were more severely affected. Patients had increased frequency and severity of changes in all points assessed with SWM compared with controls. In the analyses of concordance between CINQ and SWM, kappa = 0.320 ( p  &lt; 0.001) was obtained, and there was a moderate and positive correlation ( ρ  = 0.357; p  &lt; 0.001). Conclusion CINQ and SWM may be valid tools for diagnosing CIPN in oncology practice. SWM may identify subclinical CIPN.</description><identifier>ISSN: 0941-4355</identifier><identifier>EISSN: 1433-7339</identifier><identifier>DOI: 10.1007/s00520-014-2275-3</identifier><identifier>PMID: 24811218</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Activities of daily living ; Adult ; Analysis ; Antineoplastic Agents - adverse effects ; Brazil ; Cancer ; Chemotherapy ; Cross-Sectional Studies ; Female ; Humans ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Neoplasms - drug therapy ; Neurological disorders ; Neurotoxicity Syndromes - diagnosis ; Nursing ; Nursing Research ; Oncology ; Organoplatinum Compounds - adverse effects ; Original Article ; Paclitaxel - adverse effects ; Pain Medicine ; Peripheral Nervous System Diseases - chemically induced ; Peripheral Nervous System Diseases - diagnosis ; Psychometrics - instrumentation ; Questionnaires ; Rehabilitation Medicine ; Severity of Illness Index ; Side effects ; Surveys and Questionnaires - standards ; Taxoids - adverse effects</subject><ispartof>Supportive care in cancer, 2014-10, Vol.22 (10), p.2767-2773</ispartof><rights>Springer-Verlag Berlin Heidelberg 2014</rights><rights>COPYRIGHT 2014 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-473c80c08fae41b505b8fefe507a64f7b9d47aef60939e4aa7ee59525c6a30de3</citedby><cites>FETCH-LOGICAL-c439t-473c80c08fae41b505b8fefe507a64f7b9d47aef60939e4aa7ee59525c6a30de3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00520-014-2275-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00520-014-2275-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24811218$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>da Silva Simão, Delma Aurélia</creatorcontrib><creatorcontrib>Teixeira, Antônio Lúcio</creatorcontrib><creatorcontrib>Souza, Raissa Silva</creatorcontrib><creatorcontrib>de Paula Lima, Elenice Dias Ribeiro</creatorcontrib><title>Evaluation of the Semmes–Weinstein filaments and a questionnaire to assess chemotherapy-induced peripheral neuropathy</title><title>Supportive care in cancer</title><addtitle>Support Care Cancer</addtitle><addtitle>Support Care Cancer</addtitle><description>Objective This study aims to assess the use of Semmes–Weinstein monofilaments (SWMs) and of the Chemotherapy-Induced Neurotoxicity Questionnaire (CINQ) in the detection of chemotherapy-induced peripheral neuropathy (CIPN). Method It is a comparative and cross-sectional study performed in a philanthropic general hospital, located in the state of Minas Gerais, Brazil. One hundred seventeen individuals have participated in this study; they were divided into two groups: patients ( n  = 87) treated with oxaliplatin, paclitaxel, or docetaxel and controls ( n  = 30) without malignant disease. Results There were statistically significant differences between groups for all symptoms assessed by means of the CINQ. Lower limbs were more severely affected. Patients had increased frequency and severity of changes in all points assessed with SWM compared with controls. In the analyses of concordance between CINQ and SWM, kappa = 0.320 ( p  &lt; 0.001) was obtained, and there was a moderate and positive correlation ( ρ  = 0.357; p  &lt; 0.001). Conclusion CINQ and SWM may be valid tools for diagnosing CIPN in oncology practice. SWM may identify subclinical CIPN.</description><subject>Activities of daily living</subject><subject>Adult</subject><subject>Analysis</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Brazil</subject><subject>Cancer</subject><subject>Chemotherapy</subject><subject>Cross-Sectional Studies</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Neoplasms - drug therapy</subject><subject>Neurological disorders</subject><subject>Neurotoxicity Syndromes - diagnosis</subject><subject>Nursing</subject><subject>Nursing Research</subject><subject>Oncology</subject><subject>Organoplatinum Compounds - adverse effects</subject><subject>Original Article</subject><subject>Paclitaxel - adverse effects</subject><subject>Pain Medicine</subject><subject>Peripheral Nervous System Diseases - chemically induced</subject><subject>Peripheral Nervous System Diseases - diagnosis</subject><subject>Psychometrics - instrumentation</subject><subject>Questionnaires</subject><subject>Rehabilitation Medicine</subject><subject>Severity of Illness Index</subject><subject>Side effects</subject><subject>Surveys and Questionnaires - standards</subject><subject>Taxoids - adverse effects</subject><issn>0941-4355</issn><issn>1433-7339</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kcuKFDEYhYMoTjv6AG4k4LrGXDtVy2EYLzDgQsVl-Dv1ZzpDVVImVQ698x18Q5_ElD3eQAkkkHzn5CSHkKecnXHGzIvCmBasYVw1QhjdyHtkw5WUjZGyu082rFO8UVLrE_KolBvGuDFaPCQnQrWcC95uyO3lZxgWmEOKNHk675G-w3HE8u3L148YYpnrRH0YYMQ4Fwqxp0A_LVhWSYSQkc6JQilYCnV7HFP1yDAdmhD7xWFPJ8xhWvcGGnHJaYJ5f3hMHngYCj65W0_Jh5eX7y9eN1dvX725OL9qnJLd3CgjXcscaz2g4jvN9K716FEzA1vlza7rlQH0W9bJDhWAQdSdFtptQbIe5Sl5fvSdcvqR2t6kJcd6peW6knzbbeVv6hoGtCH6NGdwYyjOnstWCWZaLip19g-qjh7H4FLE-k34t4AfBS6nUjJ6O-UwQj5YzuzaoD02aGuDdm3QrlGe3QVediP2vxQ_K6uAOAKlHsVrzH-86L-u3wF6yahR</recordid><startdate>20141001</startdate><enddate>20141001</enddate><creator>da Silva Simão, Delma Aurélia</creator><creator>Teixeira, Antônio Lúcio</creator><creator>Souza, Raissa Silva</creator><creator>de Paula Lima, Elenice Dias Ribeiro</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88J</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HEHIP</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2R</scope><scope>M2S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20141001</creationdate><title>Evaluation of the Semmes–Weinstein filaments and a questionnaire to assess chemotherapy-induced peripheral neuropathy</title><author>da Silva Simão, Delma Aurélia ; Teixeira, Antônio Lúcio ; Souza, Raissa Silva ; de Paula Lima, Elenice Dias Ribeiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-473c80c08fae41b505b8fefe507a64f7b9d47aef60939e4aa7ee59525c6a30de3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Activities of daily living</topic><topic>Adult</topic><topic>Analysis</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Brazil</topic><topic>Cancer</topic><topic>Chemotherapy</topic><topic>Cross-Sectional Studies</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Neoplasms - drug therapy</topic><topic>Neurological disorders</topic><topic>Neurotoxicity Syndromes - diagnosis</topic><topic>Nursing</topic><topic>Nursing Research</topic><topic>Oncology</topic><topic>Organoplatinum Compounds - adverse effects</topic><topic>Original Article</topic><topic>Paclitaxel - adverse effects</topic><topic>Pain Medicine</topic><topic>Peripheral Nervous System Diseases - chemically induced</topic><topic>Peripheral Nervous System Diseases - diagnosis</topic><topic>Psychometrics - instrumentation</topic><topic>Questionnaires</topic><topic>Rehabilitation Medicine</topic><topic>Severity of Illness Index</topic><topic>Side effects</topic><topic>Surveys and Questionnaires - standards</topic><topic>Taxoids - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>da Silva Simão, Delma Aurélia</creatorcontrib><creatorcontrib>Teixeira, Antônio Lúcio</creatorcontrib><creatorcontrib>Souza, Raissa Silva</creatorcontrib><creatorcontrib>de Paula Lima, Elenice Dias Ribeiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Sociology Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Social Science Database</collection><collection>Sociology Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Supportive care in cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>da Silva Simão, Delma Aurélia</au><au>Teixeira, Antônio Lúcio</au><au>Souza, Raissa Silva</au><au>de Paula Lima, Elenice Dias Ribeiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of the Semmes–Weinstein filaments and a questionnaire to assess chemotherapy-induced peripheral neuropathy</atitle><jtitle>Supportive care in cancer</jtitle><stitle>Support Care Cancer</stitle><addtitle>Support Care Cancer</addtitle><date>2014-10-01</date><risdate>2014</risdate><volume>22</volume><issue>10</issue><spage>2767</spage><epage>2773</epage><pages>2767-2773</pages><issn>0941-4355</issn><eissn>1433-7339</eissn><abstract>Objective This study aims to assess the use of Semmes–Weinstein monofilaments (SWMs) and of the Chemotherapy-Induced Neurotoxicity Questionnaire (CINQ) in the detection of chemotherapy-induced peripheral neuropathy (CIPN). Method It is a comparative and cross-sectional study performed in a philanthropic general hospital, located in the state of Minas Gerais, Brazil. One hundred seventeen individuals have participated in this study; they were divided into two groups: patients ( n  = 87) treated with oxaliplatin, paclitaxel, or docetaxel and controls ( n  = 30) without malignant disease. Results There were statistically significant differences between groups for all symptoms assessed by means of the CINQ. Lower limbs were more severely affected. Patients had increased frequency and severity of changes in all points assessed with SWM compared with controls. In the analyses of concordance between CINQ and SWM, kappa = 0.320 ( p  &lt; 0.001) was obtained, and there was a moderate and positive correlation ( ρ  = 0.357; p  &lt; 0.001). Conclusion CINQ and SWM may be valid tools for diagnosing CIPN in oncology practice. SWM may identify subclinical CIPN.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>24811218</pmid><doi>10.1007/s00520-014-2275-3</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0941-4355
ispartof Supportive care in cancer, 2014-10, Vol.22 (10), p.2767-2773
issn 0941-4355
1433-7339
language eng
recordid cdi_proquest_journals_1559516963
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Activities of daily living
Adult
Analysis
Antineoplastic Agents - adverse effects
Brazil
Cancer
Chemotherapy
Cross-Sectional Studies
Female
Humans
Male
Medicine
Medicine & Public Health
Middle Aged
Neoplasms - drug therapy
Neurological disorders
Neurotoxicity Syndromes - diagnosis
Nursing
Nursing Research
Oncology
Organoplatinum Compounds - adverse effects
Original Article
Paclitaxel - adverse effects
Pain Medicine
Peripheral Nervous System Diseases - chemically induced
Peripheral Nervous System Diseases - diagnosis
Psychometrics - instrumentation
Questionnaires
Rehabilitation Medicine
Severity of Illness Index
Side effects
Surveys and Questionnaires - standards
Taxoids - adverse effects
title Evaluation of the Semmes–Weinstein filaments and a questionnaire to assess chemotherapy-induced peripheral neuropathy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T04%3A50%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20the%20Semmes%E2%80%93Weinstein%20filaments%20and%20a%20questionnaire%20to%20assess%20chemotherapy-induced%20peripheral%20neuropathy&rft.jtitle=Supportive%20care%20in%20cancer&rft.au=da%20Silva%20Sim%C3%A3o,%20Delma%20Aur%C3%A9lia&rft.date=2014-10-01&rft.volume=22&rft.issue=10&rft.spage=2767&rft.epage=2773&rft.pages=2767-2773&rft.issn=0941-4355&rft.eissn=1433-7339&rft_id=info:doi/10.1007/s00520-014-2275-3&rft_dat=%3Cgale_proqu%3EA384207812%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1559516963&rft_id=info:pmid/24811218&rft_galeid=A384207812&rfr_iscdi=true